Search results
Author(s):
Amer M Johri
,
Matthew I Crerar
,
Anthony J Sanfilippo
Added:
3 years ago
In this era of cost control and limited resources available to meet the growing demand for cardiovascular imaging testing, quality control initiatives that reduce the need for alternative testing are highly relevant. The implementation of continuous quality improvement (CQI) through the analysis of variations in clinical or test performance at an organizational or individual level is termed …
View more
Author(s):
Malcolm M Bersohn
Added:
3 years ago
Permanent pacemakers have been used to treat patients with symptomatic bradycardia for 45 years. The earliest pacemakers paced only the ventricle and were used primarily for patients with complete heart block. The need for atrial pacing became apparent as pacing for sinus node dysfunction became more common. Initially, only single-chamber pacing was possible in the atrium, and this was a good…
View more
Long-term Circulatory Support — The Left Ventricular Assist System for Advanced Heart Failure
Author(s):
Srinivas Murali
Added:
3 years ago
Article
Author(s):
Malcolm M Bersohn
Added:
3 years ago
Permanent pacemakers have been used to treat patients with symptomatic bradycardia for 45 years. The earliest pacemakers paced only the ventricle and were used primarily for patients with complete heart block. The need for atrial pacing became apparent as pacing for sinus node dysfunction became more common. Initially, only single-chamber pacing was possible in the atrium, and this was a good…
View more
LVAD as Destination Therapy
Author(s):
Jorge Silva Enciso
,
Eric Adler
,
Barry H Greenberg
Added:
3 years ago
Article
Author(s):
Bertram Pitt
Added:
3 years ago
The therapy of patients with chronic heart failure (HF) due to systolic left ventricular dysfunction (SLVD) continues to evolve. There is agreement that all patients with HF due to SLVD should be treated with an angiotensin converting enzyme inhibitor (ACE-I) and a beta-adrenergic receptor blocking agent (BB) unless contraindicated or not tolerated. The role of angiotensin receptor blocking…
View more
Author(s):
Abdulrahman Almoghairi
,
Nayef Al-Asiri
,
Khalid Al Johani
,
et al
Added:
8 months ago
Author(s):
Bertram Pitt
Added:
3 years ago
The therapy of patients with chronic heart failure (HF) due to systolic left ventricular dysfunction (SLVD) continues to evolve. There is agreement that all patients with HF due to SLVD should be treated with an angiotensin converting enzyme inhibitor (ACE-I) and a beta-adrenergic receptor blocking agent (BB) unless contraindicated or not tolerated. The role of angiotensin receptor blocking…
View more
Left Atrial Appendage Closure Devices for Stroke Prevention in Patients with Non-Valvular AF
Author(s):
Daniel A McBride
,
Timothy M Markman
,
Jackson J Liang
,
et al
Added:
3 years ago
Article
Author(s):
Rakesh Latchamsetty
Added:
3 years ago
Introduction
Premature ventricular complexes (PVCs) in the absence of underlying structural heart disease have long been viewed as benign. Early studies with small population sizes and limited cardiac testing suggested that long-term prognosis in patients with idiopathic PVCs is similar to those in patients without other cardiac disease, and treatment was consequently limited to provide…
View more